SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]:
SEC Accession No. 0001654954-24-004370
Filing Date
2024-04-09
Accepted
2024-04-08 18:30:30
Documents
103
Period of Report
2023-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 20-F med_20f.htm   iXBRL 20-F 2098776
2 LIST OF SIGNIFICANT med_ex81.htm EX-8.1 6054
3 CERTIFICATION med_ex121.htm EX-12.1 12339
4 CERTIFICATION med_ex122.htm EX-12.2 12121
5 CERTIFICATION med_ex131.htm EX-13.1 6969
6 CONSENT OF INDEPENDENT med_ex231.htm EX-23.1 2412
12 med_20fimg4.jpg GRAPHIC 5243
13 med_20fimg5.jpg GRAPHIC 3455
  Complete submission text file 0001654954-24-004370.txt   8066063

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA mph-20231231.xsd EX-101.SCH 87750
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE mph-20231231_lab.xml EX-101.LAB 435427
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE mph-20231231_cal.xml EX-101.CAL 65517
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mph-20231231_pre.xml EX-101.PRE 352545
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE mph-20231231_def.xml EX-101.DEF 207257
107 EXTRACTED XBRL INSTANCE DOCUMENT med_20f_htm.xml XML 1407064
Mailing Address SUITE 2 1250 WAVERLEY STREET WINNIPEG A2 R3T 6C6
Business Address SUITE 2 1250 WAVERLEY STREET WINNIPEG A2 R3T 6C6 204-487-7412
MEDICURE INC (Filer) CIK: 0001133519 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: 20-F | Act: 34 | File No.: 001-31995 | Film No.: 24830727
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)